Professor James McLaughlin, a physicist, is currently the Director of the Nanotechnology and Integrated Bioengineering Centre - NIBEC. His present research interests address nanotechnology and it’s application in areas such as point-of-care sensors and cardiology based medical diagnostics. These interests involve the integration of sensors, microfluidics, electronics and photonics. Professor McLaughlin has led key developments in the technology of sensor materials and it’s impact into the connected health industry in areas such as cardiac arrest, heart failure and ubiquitous predictive monitoring. This work has had a strong influence on the Universities commercialisation of IP relating to Connected Health companies, as well as providing the basis for a range of new biomedical sensing platforms.